RadNet (RDNT) Set to Announce Quarterly Earnings on Wednesday

RadNet (NASDAQ:RDNT) will be announcing its earnings results after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.09) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

RadNet (NASDAQ:RDNT) last posted its quarterly earnings results on Friday, March 1st. The medical research company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.09. RadNet had a net margin of 0.19% and a return on equity of 4.72%. The business had revenue of $420.38 million during the quarter, compared to the consensus estimate of $410.11 million. During the same quarter last year, the firm posted $0.11 EPS. RadNet’s revenue was up 9.5% compared to the same quarter last year. On average, analysts expect RadNet to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

RadNet Stock Performance

RDNT opened at $51.20 on Monday. RadNet has a 1-year low of $25.11 and a 1-year high of $52.40. The company has a market cap of $3.78 billion, a price-to-earnings ratio of -2,558.72 and a beta of 1.69. The company’s fifty day moving average price is $47.00 and its two-hundred day moving average price is $38.78. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 1.00.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on RDNT shares. Jefferies Financial Group lifted their price target on RadNet from $47.00 to $58.00 and gave the company a “buy” rating in a research note on Friday, March 22nd. Barclays began coverage on shares of RadNet in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $48.00 target price on the stock. StockNews.com lowered RadNet from a “hold” rating to a “sell” rating in a report on Thursday, April 11th. Finally, Truist Financial reiterated a “buy” rating and set a $55.00 price target (up from $51.00) on shares of RadNet in a report on Thursday, March 28th.

About RadNet

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.